Eiken Chemical Co., Ltd. (4549.T)
JPY 2165.0
(0.42%)
JPY 2165.0
(0.42%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 3.37 Billion JPY | -54.69% |
| 2022 | 7.45 Billion JPY | -11.09% |
| 2021 | 8.38 Billion JPY | 26.85% |
| 2020 | 6.61 Billion JPY | 43.05% |
| 2019 | 4.62 Billion JPY | 0.24% |
| 2018 | 4.61 Billion JPY | 32.58% |
| 2017 | 3.47 Billion JPY | -12.53% |
| 2016 | 3.97 Billion JPY | 12.44% |
| 2015 | 3.53 Billion JPY | 25.12% |
| 2014 | 2.82 Billion JPY | -6.05% |
| 2013 | 3 Billion JPY | 18.05% |
| 2012 | 2.54 Billion JPY | 7.78% |
| 2011 | 2.36 Billion JPY | -12.74% |
| 2010 | 2.7 Billion JPY | 42.35% |
| 2009 | 1.9 Billion JPY | 4.05% |
| 2008 | 1.82 Billion JPY | -10.82% |
| 2007 | 2.05 Billion JPY | 12.75% |
| 2006 | 1.81 Billion JPY | -9.0% |
| 2005 | 1.99 Billion JPY | 17.22% |
| 2004 | 1.7 Billion JPY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 583 Million JPY | 1594.87% |
| 2024 Q2 | 983 Million JPY | 68.61% |
| 2023 Q2 | 1.09 Billion JPY | 4.18% |
| 2023 FY | 3.37 Billion JPY | -54.69% |
| 2023 Q4 | -39 Million JPY | -103.07% |
| 2023 Q1 | 1.05 Billion JPY | 129.69% |
| 2023 Q3 | 1.26 Billion JPY | 15.78% |
| 2022 FY | 7.45 Billion JPY | -11.09% |
| 2022 Q3 | 1.34 Billion JPY | -52.99% |
| 2022 Q4 | 458 Million JPY | -65.9% |
| 2022 Q2 | 2.85 Billion JPY | 2.07% |
| 2022 Q1 | 2.79 Billion JPY | 60.49% |
| 2021 Q2 | 2.23 Billion JPY | -13.62% |
| 2021 Q4 | 1.74 Billion JPY | -3.75% |
| 2021 Q3 | 1.81 Billion JPY | -19.07% |
| 2021 Q1 | 2.59 Billion JPY | 139.78% |
| 2021 FY | 8.38 Billion JPY | 26.85% |
| 2020 FY | 6.61 Billion JPY | 43.05% |
| 2020 Q1 | 1.01 Billion JPY | 272.16% |
| 2020 Q2 | 1.7 Billion JPY | 68.11% |
| 2020 Q3 | 2.8 Billion JPY | 64.34% |
| 2020 Q4 | 1.08 Billion JPY | -61.49% |
| 2019 Q1 | 1.49 Billion JPY | 347.45% |
| 2019 FY | 4.62 Billion JPY | 0.24% |
| 2019 Q3 | 1.3 Billion JPY | -15.9% |
| 2019 Q4 | 273 Million JPY | -79.1% |
| 2019 Q2 | 1.55 Billion JPY | 4.23% |
| 2018 Q3 | 1.73 Billion JPY | 38.94% |
| 2018 FY | 4.61 Billion JPY | 32.58% |
| 2018 Q1 | 1.29 Billion JPY | 5084.62% |
| 2018 Q2 | 1.24 Billion JPY | -3.7% |
| 2018 Q4 | 333 Million JPY | -80.8% |
| 2017 Q4 | -26 Million JPY | -102.02% |
| 2017 FY | 3.47 Billion JPY | -12.53% |
| 2017 Q3 | 1.28 Billion JPY | 16.76% |
| 2017 Q2 | 1.1 Billion JPY | -0.63% |
| 2017 Q1 | 1.11 Billion JPY | 87.04% |
| 2016 FY | 3.97 Billion JPY | 12.44% |
| 2016 Q4 | 594 Million JPY | -43.8% |
| 2016 Q3 | 1.05 Billion JPY | -16.38% |
| 2016 Q2 | 1.26 Billion JPY | 19.13% |
| 2016 Q1 | 1.06 Billion JPY | 52.66% |
| 2015 Q1 | 864 Million JPY | 29.92% |
| 2015 Q2 | 1.09 Billion JPY | 26.62% |
| 2015 FY | 3.53 Billion JPY | 25.12% |
| 2015 Q4 | 695 Million JPY | -21.29% |
| 2015 Q3 | 883 Million JPY | -19.29% |
| 2014 Q2 | 1.08 Billion JPY | 39.97% |
| 2014 Q4 | 665 Million JPY | 117.32% |
| 2014 FY | 2.82 Billion JPY | -6.05% |
| 2014 Q1 | 773 Million JPY | 55.53% |
| 2014 Q3 | 306 Million JPY | -71.72% |
| 2013 Q1 | 843 Million JPY | 309.22% |
| 2013 Q3 | 873 Million JPY | 9.81% |
| 2013 Q4 | 497 Million JPY | -43.07% |
| 2013 FY | 3 Billion JPY | 18.05% |
| 2013 Q2 | 795 Million JPY | -5.69% |
| 2012 Q3 | 858 Million JPY | 27.87% |
| 2012 FY | 2.54 Billion JPY | 7.78% |
| 2012 Q1 | 814 Million JPY | 653.74% |
| 2012 Q2 | 671 Million JPY | -17.57% |
| 2012 Q4 | 206 Million JPY | -75.99% |
| 2011 Q3 | 867 Million JPY | -4.52% |
| 2011 Q1 | 736 Million JPY | 52.38% |
| 2011 FY | 2.36 Billion JPY | -12.74% |
| 2011 Q2 | 908 Million JPY | 23.37% |
| 2011 Q4 | -147 Million JPY | -116.96% |
| 2010 Q4 | 483 Million JPY | -25.12% |
| 2010 FY | 2.7 Billion JPY | 42.35% |
| 2010 Q3 | 645 Million JPY | -14.91% |
| 2010 Q2 | 758 Million JPY | -8.12% |
| 2010 Q1 | 825 Million JPY | 271.62% |
| 2009 Q1 | 625 Million JPY | 144.14% |
| 2009 FY | 1.9 Billion JPY | 4.05% |
| 2009 Q2 | 628 Million JPY | 0.48% |
| 2009 Q3 | 429 Million JPY | -31.69% |
| 2009 Q4 | 222 Million JPY | -48.25% |
| 2008 Q4 | 256 Million JPY | -37.1% |
| 2008 FY | 1.82 Billion JPY | -10.82% |
| 2008 Q3 | 407 Million JPY | -32.05% |
| 2008 Q2 | 599 Million JPY | 0.0% |
| 2007 FY | 2.05 Billion JPY | 12.75% |
| 2006 FY | 1.81 Billion JPY | -9.0% |
| 2005 FY | 1.99 Billion JPY | 17.22% |
| 2004 FY | 1.7 Billion JPY | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| DVx Inc. | 653.15 Million JPY | -417.03% |
| Seikagaku Corporation | 433 Million JPY | -679.908% |
| Create Medic Co., Ltd. | 803.24 Million JPY | -320.42% |
| PHC Holdings Corporation | 8.31 Billion JPY | 59.372% |
| Techno Medica Co., Ltd. | 1.84 Billion JPY | -83.509% |
| Rion Co., Ltd. | 3.47 Billion JPY | 2.817% |
| Nihon Kohden Corporation | 19.59 Billion JPY | 82.763% |
| Fukuda Denshi Co., Ltd. | 26.5 Billion JPY | 87.259% |
| Japan Lifeline Co., Ltd. | 10.89 Billion JPY | 68.996% |
| Japan Medical Dynamic Marketing, INC. | 1.74 Billion JPY | -93.312% |
| 3-D Matrix, Ltd. | -2.11 Billion JPY | 259.515% |
| CYBERDYNE Inc. | -1.73 Billion JPY | 294.528% |